Generic Exclusivity For Omeprazole 40 Mg Challenged By Apotex
This article was originally published in The Pink Sheet Daily
Executive Summary
A federal appeals court should rule on the validity of FDA’s patent-based approach to awarding exclusivity for Paxil generics because “it is an absolute certainty” that Apotex will litigate the same issue for Prilosec 40 mg, company attorney Rakoczy tells the appellate judges.